1. Home
  2. SCLXW vs FTAIM Comparison

SCLXW vs FTAIM Comparison

Compare SCLXW & FTAIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

N/A

Current Price

$0.14

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

FTAIM

FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares

SELL

Current Price

$26.92

Market Cap

0.0

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
SCLXW
FTAIM
Founded
N/A
N/A
Country
United States
United States
Employees
30
580
Industry
Biotechnology: Pharmaceutical Preparations
Misc Corporate Leasing Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLXW
FTAIM
Price
$0.14
$26.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0K
N/A
Earning Date
03-07-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$55,152,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.02
N/A
52 Week Low
$0.18
N/A
52 Week High
$0.18
N/A

Technical Indicators

Market Signals
Indicator
SCLXW
FTAIM
Relative Strength Index (RSI) 48.38 45.97
Support Level $0.13 $27.00
Resistance Level $0.18 $27.28
Average True Range (ATR) 0.03 0.16
MACD 0.00 -0.03
Stochastic Oscillator 50.00 10.83

Price Performance

Historical Comparison
SCLXW
FTAIM

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares

FTAI Aviation Ltd is an aerospace company. It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft, which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.

Share on Social Networks: